Fidelity National Information Services, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Fidelity National Information Services, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	9,241	9,123	8,423	10,333	12,552	9,339	9,720	9,831	10,127	10,677
Cost of revenue	5,895	5,794	5,569	6,610	8,348	5,990	6,259	6,175	6,323	6,741
Gross profit	2,936	2,874	2,854	3,723	4,204	3,349	3,461	3,656	3,804	3,936
Selling, general and administrative	1,707	1,442	1,301	2,667	3,516	2,115	2,182	2,096	2,185	2,263
Operating income	1,229	1,432	1,458	969	552	1,040	1,176	1,447	1,709	1,741
Interest expense	403	359	314	389	339	214	298	713	351	391
Interest income	20	22	17	52	5	2	17	92	101	24
Other non-operating income	-9	-119	-57	-219	48	-109	3	-164	-162	-198
Pre-tax income	837	976	1,104	413	266	789	-16,331	662	1,297	1,176
Income tax	291	-321	208	100	96	403	314	157	362	265
Income from continuing operations	524	1,261	846			320	576	502	787	382
Net income to minority interests	22	33	35	5	6	7	12	7	3	3
Net income	525	1,261	846	298	158	417	-16,752	-6,655	1,450	382
EBITDA	2,382	2,798	2,878	3,413	4,266	5,055	3,054	3,191	3,446	3,624
EPS, basic	1.61	3.82	2.58	0.67	0.26	0.68	-27.74	-11.26	2.62	0.73
EPS, diluted	1.59	3.75	2.55	0.66	0.25	0.67	-27.74	-11.26	2.61	0.73
Shares, basic (weighted)	326	330	328	445	619	616	604	591	553	523
Shares, diluted (weighted)	330	336	332	451	627	621	604	591	555	525
Dividend per share	1.04	1.16	1.28	1.40	1.40	1.56	1.88	2.08	1.44	1.60

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	683	665	703	1,152	1,959	2,010	456	440	834	599
Receivables	1,550	1,624	1,472	3,242	3,314	3,772	1,834	1,738
Other current assets	236	253	288	308	394	551	509	641	135	261
Total current assets	4,282	3,688	3,733	8,692	9,898	10,708	12,818	13,656	5,186	4,488
Property, plant and equipment	626	610	587	900	887	949	709	695	646	691
Lease right-of-use assets				564	534	462	251	214	230	231
Goodwill	14,178	13,730	13,545	52,242	53,268	16,927	16,816	16,971	17,260	17,762
Intangible assets	4,664	3,885	3,132	15,798	13,928	11,539	2,468	1,823	1,318	959
Other non-current assets	363	531	503	2,303	1,574	2,137	1,675	1,528	1,749	1,710
Total assets	26,031	24,526	23,770	83,806	83,842	82,931	63,278	54,973	33,784	33,488
Accounts payable	512	776	687	1,386	1,576	1,829	623	110	214	192
Deferred revenue	741	776	739	817	881	779	777	829	902	957
Short-term debt	332	1,045	48	140	1,314	1,617	2,130	1,348	968	1,284
Total current liabilities	3,151	4,011	3,125	10,382	12,361	14,466	16,224	18,229	6,094	7,616
Long-term debt	10,146	7,718	8,670	17,229	15,951	14,825	14,206	12,970	9,686	9,069
Lease liabilities				466	453	378	219	178	177	178
Other non-current liabilities	386	403	326	2,406	2,026	1,915	1,382	1,446	1,441	1,686
Total liabilities	16,186	13,706	13,548	34,350	34,355	35,399	35,872	35,917	18,084	19,586
Total debt	10,478	8,763	8,718	17,369	17,265	16,442	16,336	14,318	10,654	10,353
Paid-in capital	10,380	10,534	10,800	45,358	45,947	46,466	46,735	46,933	47,129	47,317
Retained earnings	3,299	4,109	4,528	4,161	3,440	2,889	-14,971	-22,905	-22,257	-22,718
Treasury stock	-3,611	-3,604	-4,687	-52	-150	-2,266	-4,192	-4,724	-8,816	-10,202
Other comprehensive income	-331	-332	-430	-33	57	252	-360	-260	-364	-504
Shareholders' equity	9,741	10,711	10,215	49,440	49,300	47,347	27,218	19,050	15,698	13,899
Minority interests	104	109	7	16	13	11	8	6	2	3
Total equity	9,779	10,820	10,222	49,456	49,313	47,350	27,186	19,056	15,700	13,902
Total liabilities and equity	26,031	24,526	23,770	83,806	83,842	82,931	63,278	54,973	33,784	33,488

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	547	1,294	881	303	164	424	-16,740	-6,648	1,453	385
Depreciation and amortization	1,153	1,366	1,420	2,444	3,714	4,015	1,878	1,744	1,737	1,883
Stock-based compensation	137	107	84	402	283	383	189	120	186	181
Deferred income tax	-190	-985	-116	-109	-206	-81	-388	-415	-204	-31
Change in receivables	42	-232	78	-161	-75	-552	-247	341	-94	-246
Change in payables	95	115	-162	-74	217	391	-16	91	72	218
Cash from operations	1,925	1,741	1,993	2,410	4,442	4,810	3,939	4,335	2,175	2,608
Capital expenditures	-145	-145	-127	-200	-263	-320	-227	-115	-97	-154
Acquisitions	0	0	0	-6,632	-469	-767	0	-202	-514	-573
Cash from investing	-619	690	-668	-7,501	-914	-1,771	-373	-1,352	8,178	-3,042
Debt issued	7,745	9,615	26,371	33,352	47,695	54,073	75,293	93,087	25,430	55,428
Debt repaid	-8,749	-11,689	-26,148	-24,672	-49,067	-53,440	-74,304	-94,444	-33,175	-54,348
Stock issued	112	208	288	161	332	121	57	41	3	8
Share buybacks	-40	-153	-1,255	-453	-112	-2,114	-1,938	-522	-4,045	-1,425
Dividends paid	-341	-385	-421	-656	-868	-961	-1,138	-1,231	-800	-847
Cash from financing	-1,309	-2,480	-1,236	7,581	-2,751	-2,538	-2,573	-3,493	-12,550	-1,179
Exchange rate effect	4	31	-51	18	42	-248	-42	5	-31	58
Net change in cash	1	-18	38	2,508	819	253	530	-399	-2,468	-1,347
Free cash flow	1,780	1,596	1,866	2,210	4,179	4,490	3,712	4,220	2,078	2,454
Interest paid	351	354	298	332	428	491	417	696	396	401
Income taxes paid	341	545	503	321	282	440	963	402	488	628

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $35.41 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	35.9%	Gross profit / revenue.
Operating margin	15.7%	Operating income / revenue.
EBITDA margin	34.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	11.1%	Pre-tax income / revenue.
Net margin	27.6%	Net income / revenue.
FCF margin	23.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	24.4%	Cash from operations / revenue.
Effective tax rate	25.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	21.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	7.6%	Net income / average total assets.
Return on invested capital (ROIC)	4.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	19.9%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.5%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.3%	Capital expenditures / revenue.
D&A / revenue	18.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	5.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	3.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-3.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	3.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	4.4%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-1.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	1.9%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	14.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	25.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	5.2%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	5.9%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-3.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-73.7%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 5y	19.3%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-72.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 5y	23.9%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	19.9%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-12.8%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-10.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	18.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-12.9%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-10.1%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	11.1%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	-5.2%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	2.7%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-11.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-20.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-22.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-0.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-19.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-16.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-5.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-4.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-3.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.53x	Current assets / current liabilities.
Quick ratio	0.08x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.08x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.06x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	38.4%	Total debt / total assets.
Liabilities / assets	63.6%	Total liabilities / total assets.
Net debt	$16.20B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.90x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	3.20x	Operating income / interest expense.
Working capital	-$4.59B	Current assets - current liabilities.
Goodwill and intangibles / assets	66.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$13.30B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.28x	Revenue / average total assets.
Fixed asset turnover	10.7x	Revenue / average property, plant and equipment.
Days payables	15 days	365 x average accounts payable / cost of revenue.
FCF conversion	83.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	5.2%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$6.52	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$23.60	Revenue / diluted weighted shares.
FCF per share	$5.46	Free cash flow / diluted weighted shares.
Operating cash flow per share	$5.76	Cash from operations / diluted weighted shares.
Book value per share	$31.02	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$25.73	Tangible book value / shares outstanding.
Cash per share	$1.44	(Cash + short-term investments) / shares outstanding.
Payout ratio	25.9%	Dividends paid / net income, when net income is positive.
Dividends / FCF	31.0%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	25.5%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$18.26B	Share price x shares outstanding.
Enterprise value	$34.47B	Market cap + total debt - cash - short-term investments.
P/E	5.42x	Market cap / net income. Only when net income is positive.
P/S	1.50x	Market cap / revenue.
P/B	1.14x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	6.47x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	6.14x	Market cap / cash from operations, when positive.
EV/Sales	2.82x	Enterprise value / revenue.
EV/EBIT	18.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	8.29x	Enterprise value / EBITDA, when both are positive.
EV/FCF	12.2x	Enterprise value / free cash flow, when both are positive.
FCF yield	15.5%	Free cash flow / market cap.
Earnings yield	18.5%	Net income / market cap (the inverse of P/E).
Dividend yield	4.8%	Dividends paid over the period / market cap.
Shareholder yield	8.7%	(Dividends paid + share buybacks) / market cap.

What was Fidelity National Information Services, Inc.'s revenue in fiscal 2025?

Fidelity National Information Services, Inc. reported revenue of $10.68B for fiscal 2025, 5.4% higher than the year before.

Was Fidelity National Information Services, Inc. profitable in fiscal 2025?

Yes. Net income was $382.0M, a net margin of 3.6%.

How much free cash flow did Fidelity National Information Services, Inc. generate in fiscal 2025?

Cash from operations of $2.61B minus capital expenditures of $154.0M left free cash flow of $2.45B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Fidelity National Information Services, Inc.